Global Bio-Chem Technology Group Completes Private Placement and Convertible Bond Conversion, Issuing Over 2.75 Billion New Shares

Reuters

10/02

<a href="https://laohu8.com/S/00809">Global Bio-Chem</a> Technology Group Completes Private Placement and Convertible Bond Conversion, Issuing Over 2.75 Billion New Shares

Global Bio-Chem Technology Group Co. Ltd. has announced the completion of a significant equity transaction involving the issuance of 2,752,605,977 new consideration shares under a specific mandate. The move forms part of a broader suppliers' debt restructuring arrangement. The company also confirmed the conversion of its convertible bonds as part of the deal. Following the transaction, key shareholdings are now attributed to entities including ShengLi IX and Modern Agricultural Industry Investment Holdings Limited, with indirect interests held by various investment funds and state-owned enterprises. The transaction aims to improve the company's financial position and broaden its shareholder base.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Global Bio-Chem Technology Group Co. Ltd. published the original content used to generate this news brief on October 02, 2025, and is solely responsible for the information contained therein.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2572851940"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2572851940\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2572851940?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-10-02 19:11","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2572851940","market":"fut","top_or_hot":-1,"title":"Global Bio-Chem Technology Group Completes Private Placement and Convertible Bond Conversion, Issuing Over 2.75 Billion New Shares","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      <a href=\"https://laohu8.com/S/00809\">Global Bio-Chem</a> Technology Group Completes Private Placement and Convertible Bond Conversion, Issuing Over 2.75 Billion New Shares\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Global Bio-Chem Technology Group Co. Ltd. has announced the completion of a significant equity transaction involving the issuance of 2,752,605,977 new consideration shares under a specific mandate. The move forms part of a broader suppliers' debt restructuring arrangement. The company also confirmed the conversion of its convertible bonds as part of the deal. Following the transaction, key shareholdings are now attributed to entities including ShengLi IX and Modern Agricultural Industry Investment Holdings Limited, with indirect interests held by various investment funds and state-owned enterprises. The transaction aims to improve the company's financial position and broaden its shareholder base.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Global Bio-Chem Technology Group Co. Ltd. published the original content used to generate this news brief on October 02, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Global Bio-Chem Technology Group Completes Private Placement and Convertible Bond Conversion, Issuing Over 2.75 Billion New Shares</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGlobal Bio-Chem Technology Group Completes Private Placement and Convertible Bond Conversion, Issuing Over 2.75 Billion New Shares\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-10-02 19:11</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      <a href=\"https://laohu8.com/S/00809\">Global Bio-Chem</a> Technology Group Completes Private Placement and Convertible Bond Conversion, Issuing Over 2.75 Billion New Shares\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Global Bio-Chem Technology Group Co. Ltd. has announced the completion of a significant equity transaction involving the issuance of 2,752,605,977 new consideration shares under a specific mandate. The move forms part of a broader suppliers' debt restructuring arrangement. The company also confirmed the conversion of its convertible bonds as part of the deal. Following the transaction, key shareholdings are now attributed to entities including ShengLi IX and Modern Agricultural Industry Investment Holdings Limited, with indirect interests held by various investment funds and state-owned enterprises. The transaction aims to improve the company's financial position and broaden its shareholder base.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Global Bio-Chem Technology Group Co. Ltd. published the original content used to generate this news brief on October 02, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1212","symbol_name":"农产品","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251002:nNDL7vCBcN:1","article_id":"2572851940","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2572851940","pubTimestamp":1759403519,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"Global Bio-Chem Technology Group Completes Private Placement and Convertible Bond Conversion, Issuing Over 2.75 Billion New Shares. Global Bio-Chem Technology Group Co. Ltd. has announced the completion of a significant equity transaction involving the issuance of 2,752,605,977 new consideration shares under a specific mandate. The move forms part of a broader suppliers' debt restructuring arrangement. The company also confirmed the conversion of its convertible bonds as part of the deal. Following the transaction, key shareholdings are now attributed to entities including ShengLi IX and Modern Agricultural Industry Investment Holdings Limited, with indirect interests held by various investment funds and state-owned enterprises. The transaction aims to improve the company's financial position and broaden its shareholder base.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely informa","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK1212":"农产品","00809":"大成生化科技"},"translate_title":"环球生化科技集团完成定向增发及可转债转股发行超27.5亿新股","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"00809":0.9},"content_text":"Global Bio-Chem Technology Group Completes Private Placement and Convertible Bond Conversion, Issuing Over 2.75 Billion New Shares\n    \n\n        Global Bio-Chem Technology Group Co. Ltd. has announced the completion of a significant equity transaction involving the issuance of 2,752,605,977 new consideration shares under a specific mandate. The move forms part of a broader suppliers' debt restructuring arrangement. The company also confirmed the conversion of its convertible bonds as part of the deal. Following the transaction, key shareholdings are now attributed to entities including ShengLi IX and Modern Agricultural Industry Investment Holdings Limited, with indirect interests held by various investment funds and state-owned enterprises. The transaction aims to improve the company's financial position and broaden its shareholder base.\n      \n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Global Bio-Chem Technology Group Co. Ltd. published the original content used to generate this news brief on October 02, 2025, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-2","news_tag":"shareholding","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}